Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 273 No 7327 p776
27 November 2004

This article
Reprint   Photocopy

  Acrobat Reader


News summary

Related websites
UNAIDS/WHO report on HIV incidence (more)
UNAIDS/WHO/UNICEF recommendations for co-trimoxazole prophylaxis in children (PDF 310K)


HIV cases rise ahead of World AIDS day

The red ribbon is an international symbol of AIDS awareness

The red ribbon is an international symbol of AIDS awareness

The number of women infected with HIV has risen to 17.6 million, a report published in advance of World AIDS day, has revealed.

According to the United Nations Programme on HIV/AIDS and the World Health Organization the steepest increases have been in East Asia, followed by Eastern Europe and Central Asia. The total number of people estimated to be infected with the virus has also increased and now stands at 39.4 million, a 2.8 million increase since 2002.

WHO has also issued revised recommendations on the use of co-trimoxazole prophylaxis in children infected with HIV. It says that co-trimoxazole remains important even with increasing access to antiretroviral therapy, because its use can improve survival, independently of specific HIV treatment.

The new guidance states: “Prophylactic dosing with co-trimoxazole for HIV infected children with any sign or symptoms suggestive of HIV is a key intervention that should be offered as part of a basic package of care to reduce morbidity and mortality.

“Co-trimoxazole prophylaxis is also a crucial potentially life-saving intervention that should be given to all HIV-exposed children born to HIV-infected mothers, in settings where HIV infection status cannot be reliably confirmed in the first 18 months of life.”


World AIDS day is on 1 December.

Back to Top


©The Pharmaceutical Journal